Measurement of dosimetric parameters for the Alpha-Omega high-dose-rate Iridium-192 source

Area of Science:

• Medical Physics
• Radiation Oncology
• Nuclear Medicine

Background:

• The Alpha-Omega (192)Ir source is utilized in the Nucletron MicroSelectron HDR afterloader for brachytherapy.
• Accurate dosimetric characterization of radiation sources is crucial for effective cancer treatment.
• Previous dosimetric data for (192)Ir HDR sources may not fully represent the Alpha-Omega model.

Purpose of the Study:

• To perform thermoluminescent dosimetry (TLD) measurements for the Alpha-Omega (192)Ir HDR source.
• To determine the dose-rate constant, anisotropy function, and radial dose function.
• To compare these measured parameters with existing Monte Carlo calculations and previous source data.

Main Methods:

• Thermoluminescent dosimetry (TLD) was employed for precise dose measurements.
• Key dosimetric parameters including dose-rate constant, anisotropy, and radial dose function were quantified.
• Experimental results were rigorously compared against published Monte Carlo simulations.

Main Results:

• TLD measurements yielded values for the dose-rate constant, anisotropy function, and radial dose function.
• The measured dosimetric parameters showed good agreement with available Monte Carlo calculations.
• No significant dosimetric differences were observed between the Alpha-Omega source and previously characterized sources within experimental uncertainty.

Conclusions:

• The Alpha-Omega (192)Ir HDR source exhibits dosimetric characteristics consistent with prior models.
• TLD measurements validate the accuracy of Monte Carlo simulations for this source.
• This confirms the reliability of the Alpha-Omega source for consistent and precise brachytherapy applications.